Related references
Note: Only part of the references are listed.European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Marko Babjuk et al.
EUROPEAN UROLOGY (2022)
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2021)
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2021)
Psoas Muscle Mass can Predict Postsurgical Outcomes in Patients Who Undergo Radical Cystectomy and Urinary Diversion Reconstruction
Judith Stangl-Kremser et al.
UROLOGY (2021)
Imaging of sarcopenia: old evidence and new insights
Domenico Albano et al.
EUROPEAN RADIOLOGY (2020)
Molecular markers in bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2019)
The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy
Ross J. Mason et al.
CLINICAL GENITOURINARY CANCER (2018)
Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
Neil J. Kocher et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer
Roman Mayr et al.
WORLD JOURNAL OF UROLOGY (2018)
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
Hiroshi Fukushima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma
K. Harada et al.
DISEASES OF THE ESOPHAGUS (2016)
Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2016)
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Se-Il Go et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection
Pranav Sharma et al.
WORLD JOURNAL OF UROLOGY (2015)
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications
Bas W. G. van Rhijn et al.
MODERN PATHOLOGY (2015)
Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy Impact on Cancer-Specific and All-Cause Mortality
Sarah P. Psutka et al.
CANCER (2014)
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
E. Xylinas et al.
BRITISH JOURNAL OF CANCER (2013)
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
N. Harimoto et al.
BRITISH JOURNAL OF SURGERY (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
Jinsung Park et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Jesus Fernandez-Gomez et al.
JOURNAL OF UROLOGY (2009)
Share Paper
